These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2416823)

  • 1. Changes in thymocyte proliferation at different stages of viral leukemogenesis in AKR mice.
    O'Donnell PV; Traganos F
    J Immunol; 1986 Jan; 136(2):720-7. PubMed ID: 2416823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stages in development of mink cell focus-inducing (MCF) virus-accelerated leukemia in AKR mice.
    O'Donnell PV; Woller R; Chu A
    J Exp Med; 1984 Sep; 160(3):914-34. PubMed ID: 6236277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of leukemosuppressive immunotherapy on thymic infectious cell centers in AKR mice.
    Buckheit RW; Liberman SN; Bolognesi DP; Weinhold KJ
    Thymus; 1988-1989; 12(3):143-56. PubMed ID: 3266951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of lymphoma in the thymus of AKR mice treated with the lymphomagenic virus SL 3-3.
    Hays EF; Bristol GC; McDougall S; Klotz JL; Kronenberg M
    Cancer Res; 1989 Aug; 49(15):4225-30. PubMed ID: 2545338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigens shared by thymic stromal cells and T lymphocytes are abnormally expressed in AKR thymuses.
    Tucek CL; Boyd RL; Hiai H
    Thymus; 1989; 14(1-3):95-107. PubMed ID: 2623744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems.
    Azuma H; Phillips JD; Green WR
    J Immunol; 1987 Oct; 139(7):2464-73. PubMed ID: 2821116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation.
    Wustrow TP; Good RA
    Cancer Res; 1985 Dec; 45(12 Pt 1):6428-35. PubMed ID: 2998600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early clonality and high-frequency proviral integration into the c-myc locus in AKR leukemias.
    O'Donnell PV; Fleissner E; Lonial H; Koehne CF; Reicin A
    J Virol; 1985 Aug; 55(2):500-3. PubMed ID: 2991574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stem cell antigens Sca-1 and Sca-2 subdivide thymic and peripheral T lymphocytes into unique subsets.
    Spangrude GJ; Aihara Y; Weissman IL; Klein J
    J Immunol; 1988 Dec; 141(11):3697-707. PubMed ID: 2460547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells.
    Sutherland RL; Hall RE; Taylor IW
    Cancer Res; 1983 Sep; 43(9):3998-4006. PubMed ID: 6871841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of immature (Lyt-2-/L3T4-) thymocytes. Identification of four major phenotypically distinct subsets differing in cell cycle status and in vitro activation requirements.
    Howe RC; MacDonald HR
    J Immunol; 1988 Feb; 140(4):1047-55. PubMed ID: 3257768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of early stages of T lymphocyte development in the thymus cortex and medulla.
    Scollay R; Shortman K
    J Immunol; 1985 Jun; 134(6):3632-42. PubMed ID: 3886788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
    Manjunath R; Graziano RF; Green WR
    J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymic epithelium controls thymocyte expression of preleukemic phenotype and leukemogenic retroviruses.
    Tempelis LD
    J Immunol; 1987 May; 138(10):3555-65. PubMed ID: 3033077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon.
    Bekesi JG; Roboz JP; Zimmerman E; Holland JF
    Cancer Res; 1976 Feb; 36(2 pt 2):631-9. PubMed ID: 1082796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of thymocyte subpopulations in organ culture: correlated analysis of Lyt-2 phenotype and cell cycle status by flow microfluorometry.
    Sékaly RP; Ceredig R; MacDonald HR
    J Immunol; 1983 Sep; 131(3):1085-9. PubMed ID: 6604087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CTL-defined, AKR/Gross retrovirus-associated tumor antigens by normal spleen cells: control by Fv-1, H-2, and proviral genes and effect on antiviral CTL generation.
    Green WR
    J Immunol; 1986 Jan; 136(1):308-12. PubMed ID: 2999246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.